UA95103C2 - Substituted arylsulfonamides as antiviral agents - Google Patents
Substituted arylsulfonamides as antiviral agentsInfo
- Publication number
- UA95103C2 UA95103C2 UAA200811582A UAA200811582A UA95103C2 UA 95103 C2 UA95103 C2 UA 95103C2 UA A200811582 A UAA200811582 A UA A200811582A UA A200811582 A UAA200811582 A UA A200811582A UA 95103 C2 UA95103 C2 UA 95103C2
- Authority
- UA
- Ukraine
- Prior art keywords
- antiviral agents
- substituted arylsulfonamides
- arylsulfonamides
- substituted
- prophylaxis
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/73—Unsubstituted amino or imino radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
The invention relates to substituted arylsulfonamides of formula (I) and to processes for preparing them, to their use for producing medicaments for the treatment and/or prophylaxis of diseases, particularly for use as antiviral agents, especially against cytomegaloviruses., (I)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102006009928A DE102006009928A1 (en) | 2006-03-03 | 2006-03-03 | Substituted arylsulfonamides |
Publications (1)
Publication Number | Publication Date |
---|---|
UA95103C2 true UA95103C2 (en) | 2011-07-11 |
Family
ID=38180640
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA200811582A UA95103C2 (en) | 2006-03-03 | 2007-02-26 | Substituted arylsulfonamides as antiviral agents |
Country Status (26)
Country | Link |
---|---|
US (1) | US8318761B2 (en) |
EP (1) | EP1991529B1 (en) |
JP (1) | JP5255455B2 (en) |
KR (1) | KR101447758B1 (en) |
CN (1) | CN101389607B (en) |
AR (1) | AR059710A1 (en) |
AT (1) | ATE451356T1 (en) |
AU (1) | AU2007222689B2 (en) |
BR (1) | BRPI0707068A2 (en) |
CA (1) | CA2642602C (en) |
DE (2) | DE102006009928A1 (en) |
DK (1) | DK1991529T3 (en) |
ES (1) | ES2335316T3 (en) |
HK (1) | HK1125371A1 (en) |
IL (1) | IL193449A (en) |
JO (1) | JO2581B1 (en) |
MX (1) | MX2008011264A (en) |
PE (1) | PE20080136A1 (en) |
PL (1) | PL1991529T3 (en) |
PT (1) | PT1991529E (en) |
RU (1) | RU2423352C2 (en) |
TW (1) | TWI388559B (en) |
UA (1) | UA95103C2 (en) |
UY (1) | UY30178A1 (en) |
WO (1) | WO2007101573A1 (en) |
ZA (1) | ZA200807189B (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10319612A1 (en) | 2003-05-02 | 2004-11-18 | Bayer Healthcare Ag | Substituted dihydroquinazolines |
EP2103638A1 (en) * | 2008-03-20 | 2009-09-23 | Bayer MaterialScience AG | Hydrophilic polyurethane solutions |
EP2103318A1 (en) * | 2008-03-20 | 2009-09-23 | Bayer MaterialScience AG | Medical devices with hydrophilic coatings |
EP2103316A1 (en) * | 2008-03-20 | 2009-09-23 | Bayer MaterialScience AG | Hydrophilic polyurethane dispersions |
EP2103317A1 (en) * | 2008-03-20 | 2009-09-23 | Bayer MaterialScience AG | Medical devices with hydrophilic coatings |
DE102008025613A1 (en) * | 2008-05-28 | 2009-12-03 | Bayer Materialscience Ag | Hydrophilic polyurethane coatings |
DE102008025614A1 (en) * | 2008-05-28 | 2009-12-03 | Bayer Materialscience Ag | Hydrophilic polyurethane coatings |
CA2735744A1 (en) | 2008-09-04 | 2010-03-11 | Bayer Materialscience Ag | Tcd based hydrophilic polyurethane dispersions |
DE102011101446A1 (en) | 2011-05-10 | 2012-11-15 | Aicuris Gmbh & Co. Kg | Production of Dense Bodies (DB) |
EP2853532B1 (en) * | 2013-09-28 | 2020-12-09 | Instytut Farmakologii Polskiej Akademii Nauk | 1,2,4-oxadiazole derivatives as allosteric modulators of metabotropic glutamate receptors belonging to group III |
CN109879817B (en) * | 2019-03-19 | 2020-10-02 | 扬州大学 | Preparation method of mesosulfuron-methyl |
RU2738848C1 (en) * | 2019-10-24 | 2020-12-17 | Общество с ограниченной ответственностью "Научно-исследовательский институт ХимРар" (ООО "НИИ ХимРар") | Hepatitis b virus (hbv) inhibitor, which is a derivative of n-{3-[6-(dialkylamino)pyridazine-3-yl]phenyl}aryl sulphonamide derivatives and derivatives of n-{4-[6-(dialkylamino)pyridazine-3-yl]phenyl}aryl sulphonamide |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19802437A1 (en) | 1998-01-23 | 1999-07-29 | Bayer Ag | Use of N-aminophenyl sulfonamides for treating or preventing viral infections, particularly herpes |
CA2367395A1 (en) | 1999-04-19 | 2000-10-26 | Shionogi & Co., Ltd. | Cyclic amine derivatives and use thereof |
DE19920790A1 (en) * | 1999-05-06 | 2000-11-09 | Bayer Ag | Bis-sulfonamides with anti-HCMV activity |
DE19930075A1 (en) | 1999-06-30 | 2001-01-04 | Bayer Ag | New amino and amidosulfonamides as antiviral agents |
SK12662003A3 (en) * | 2001-04-19 | 2004-04-06 | Bayer Aktiengesellschaft | Arylsulfonamides as antiviral agents |
DE10138578A1 (en) | 2001-08-06 | 2003-02-27 | Bayer Ag | Heterocyclylarylsulfonamide |
-
2006
- 2006-03-03 DE DE102006009928A patent/DE102006009928A1/en not_active Withdrawn
-
2007
- 2007-02-26 MX MX2008011264A patent/MX2008011264A/en active IP Right Grant
- 2007-02-26 PT PT07722932T patent/PT1991529E/en unknown
- 2007-02-26 BR BRPI0707068-3A patent/BRPI0707068A2/en not_active Application Discontinuation
- 2007-02-26 KR KR1020087024156A patent/KR101447758B1/en active IP Right Grant
- 2007-02-26 JP JP2008557628A patent/JP5255455B2/en not_active Expired - Fee Related
- 2007-02-26 DK DK07722932.6T patent/DK1991529T3/en active
- 2007-02-26 EP EP07722932A patent/EP1991529B1/en active Active
- 2007-02-26 WO PCT/EP2007/001620 patent/WO2007101573A1/en active Application Filing
- 2007-02-26 CN CN2007800066327A patent/CN101389607B/en active Active
- 2007-02-26 RU RU2008139195/04A patent/RU2423352C2/en active
- 2007-02-26 ES ES07722932T patent/ES2335316T3/en active Active
- 2007-02-26 PL PL07722932T patent/PL1991529T3/en unknown
- 2007-02-26 CA CA2642602A patent/CA2642602C/en active Active
- 2007-02-26 AT AT07722932T patent/ATE451356T1/en active
- 2007-02-26 UA UAA200811582A patent/UA95103C2/en unknown
- 2007-02-26 DE DE502007002264T patent/DE502007002264D1/en active Active
- 2007-02-26 AU AU2007222689A patent/AU2007222689B2/en active Active
- 2007-02-28 UY UY30178A patent/UY30178A1/en active IP Right Grant
- 2007-03-01 JO JO200762A patent/JO2581B1/en active
- 2007-03-02 TW TW096107166A patent/TWI388559B/en active
- 2007-03-02 PE PE2007000224A patent/PE20080136A1/en active IP Right Grant
- 2007-03-02 AR ARP070100858A patent/AR059710A1/en not_active Application Discontinuation
-
2008
- 2008-08-14 IL IL193449A patent/IL193449A/en active IP Right Grant
- 2008-08-20 ZA ZA2008/07189A patent/ZA200807189B/en unknown
- 2008-09-03 US US12/203,793 patent/US8318761B2/en active Active
-
2009
- 2009-05-05 HK HK09104156.3A patent/HK1125371A1/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UA95103C2 (en) | Substituted arylsulfonamides as antiviral agents | |
NL300933I2 (en) | Letermovir | |
HK1093729A1 (en) | Substituted quinolones | |
CA2897273C (en) | Benzylamine derivatives | |
TNSN08283A1 (en) | Cytotoxic agents comprising new tomaymycin derivatives and their therapeutic use | |
UA102251C2 (en) | Aminidihydrothiazine derivatives as bace inhibitors for the treatment of alzheimer's disease | |
MX2009007104A (en) | Substituted oxindole derivatives and their use as vasopressin receptor ligands. | |
GB0625648D0 (en) | Compounds | |
MX2012004525A (en) | Compounds. | |
MX2011008899A (en) | Novel ortho-aminoamides for the treatment of cancer. | |
TW200724532A (en) | Pyrimidinecarboxylic acid derivatives and their use | |
TW200716564A (en) | Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents | |
WO2006089664A3 (en) | Heterocyclylamide-substituted imidazoles | |
MY150931A (en) | Substituted oxazolidinones and their use | |
MX2009001315A (en) | Substituted dimethylcyclobutyl compounds, their preparation and use in medicaments. | |
HK1112228A1 (en) | Substituted azachinzolines having an antiviral action | |
TW200621703A (en) | Alkylidene-tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents | |
IL187001A0 (en) | Preparation of (s)-4-fluromethyl-dihydro-furan -2-one | |
JO2999B1 (en) | Tricyclic Compound And Pharmaceutical Use Therof | |
TW200738611A (en) | 9-Chloro-15-deoxyprostaglandin derivatives, process for their preparation and their use as medicaments | |
UA95630C2 (en) | Lysobactin amides, processes for the preparation thereof and use thereof as antibacterial agent | |
GB0609897D0 (en) | Compounds | |
MY151590A (en) | Substituted quinolones iii | |
AU2012307449A8 (en) | Sulfonic acid salts of heterocyclylamide-substituted imidazoles | |
ATE553088T1 (en) | SUBSTITUTED QUINOLONES II |